Kidney diseases are extremely common in the world. Statistics show that more than 8% of Europeans (about 40 million) suffer from kidney diseases, with 70% of cases occurring in women. In the past years there was an increase the number of patients with chronic kidney diseases.
Chronic kidney disease is a loss of renal function by 30% or more for three months or more. Not always a person can immediately notice malfunction of the kidneys, and the disease can progress unnoticed, acquiring advanced forms. When kidney functions with not more than 10%, we speak of renal failure.
Today, traditional methods of treatment of chronic kidney diseases include dialysis and transplantation. However, in the first case, the patient is "bound" to hospital care, and the second case requires surgical intervention, and the spreading of disease causes an acute shortage of donors.
That's why scientists and doctors around the world are actively looking for new ways to restore kidney function. Cell technology offers an alternative solution.
Mesenchymal stem cells for the treatment of chronic renal failure.
Studies have shown that introduction of mesenchymal stem cells (MSCs) is particularly effective. These cells are able to differentiate into various cells of the body. When injected into the body, these cells encourage the growth of kidney cells, preventing them from dying and stimulating regenerative functions of kidney cells. MSCs replace damaged tissue cells, thereby restoring the functions of kidney. Introduction of stem cells stimulates the formation of new vascular pathways and strengthens weak blood vessels.
In the treatment of chronic renal failure, stem cells restore lost kidney function and strengthen the immune system of the body.
It is particularly important that the treatment be started at early stages of chronic renal failure, which may prevent the risk to other organs - heart and lungs, nervous and endocrine systems, as well as a failure of immune system.
Induced pluripotent stem cells in the treatment of kidney disease.
Another innovative cellular technology used for the treatment of chronic diseases is the introduction of induced pluripotent stem cells (iPSC). These are adult stem cells, which are programmed in such a manner that they acquire the characteristics of embryonic stem cells and the ability to develop into any cell or tissue in the body. Scientists have achieved amazing results, and can grow kidney cells out of iPS cells.
Particularly effective is the application of stem cells in the early stages of the disease.
We offer our patients a modern, proven, reliable cellular therapy technology based on ultra-modern health care in Japan.
Treatment of Alport syndrome.
Alport syndrome - an inherited disease characterized by renal malfunction with progressive loss of kidney function leading to kidney failure at a young age. In addition, patients often lose hearing and vision.
The currently used treatments can slow the progress of the disease, but do not cure it. In their experiments, scientists have shown that the use of bone marrow stem cells has a good therapeutic effect. Despite the severe stage of the disease, after cell transplantation, there was significant improvement in renal function. Condition of patients (even at late stages of the disease) improved immediately after the stem cells were administered.
After receiving your information our medical expert will examine it and give an answer about the possibility and feasibility of using cell therapy particularly in your case.
T: +65 97579569
T: +60 32 716 7235
Mobile: +60 16 320 7572
United Arab Emirates Branch
Hong Kong Branch
T: +852 9057 3215